Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous)
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Pilot randomised trial to assess recruitment for a larger trial to compare the efficacy and adverse effects of the subcutaneous and transvenous ICD in patients with hypertrophic cardiomyopathy (HCM) and indication for ICD therapy, with no requirement for pacing
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Hypertrophic Cardiomyopathy and a referred for ICD therapy with no pacing requirement.
Locations
Other Locations
United Kingdom
St Bartholomew's Hospital
RECRUITING
London
Contact Information
Primary
Syed Ahsan, PhD
syedahsan@nhs.net
02074804899
Backup
Christopher Monkhouse, BSc
Time Frame
Start Date: 2024-01-10
Estimated Completion Date: 2026-01-10
Participants
Target number of participants: 20
Treatments
Active_comparator: Transvenous Implantable Defibrillator
Routine TV ICD implant
Active_comparator: Subcutaneous Implantable Defibrillator
SICD ICD implant as per study protocol
Related Therapeutic Areas
Sponsors
Collaborators: Boston Scientific Corporation, Queen Mary University of London
Leads: Barts & The London NHS Trust